<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener("load", function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <iframe src="http://www.blogger.com/navbar.g?targetBlogID=6223270&amp;blogName=James+Hatton+on+licensing&amp;publishMode=PUBLISH_MODE_FTP&amp;navbarType=BLUE&amp;layoutType=CLASSIC&amp;homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2F&amp;blogLocale=en_CA&amp;searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" marginwidth="0" marginheight="0" scrolling="no" frameborder="0" height="30px" width="100%" id="navbar-iframe" title="Blogger Navigation and Search"></iframe> <div></div>

Tuesday, January 31, 2006

Avanir Novartis Research, Development and Commercialization Agreement

From the press release and the full text:

Avanir Novartis Research, Development and Commercialization Agreement

  • global agreement inflammatory diseases

  • $200 million in combined upfront and milestone payments

  • increasing royalties on worldwide product sales

  • research funding of up to $2.5 million per year for up to four years

  • Novartis responsible for product development expenses

2:25 PM

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home